Pharmaceutical manufacturer Adcock Ingram increased its dividend due to higher revenue, trading profit and profit.

The company, valued at R8.73bn on the JSE, reported that its profit increased by almost one fifth, trading profit 15% and revenue 8% year on year in the six months to end-December as the interim dividend was hiked 20% to 125c...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.